In northern blot analysis a higher expression of MUC3 and MUC4 was reported in early stage ovarian tumor samples compared to the late stage ovarian tumor samples and it was proposed that they provided a protective function in ovarian cancer [47]. Here, MUC4 is linked to ovarian carcinoma.